Metric Finance
LearnFAQ
LearnFAQ

Learn / SANA

NASDAQ: SANA

Sana Biotechnology (SANA) stock, explained like you're 5

Sana Biotechnology trades on the Nasdaq under the ticker SANA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 835 million dollars.

Ticker
SANA
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Small cap, about 835 million dollars

Is Sana Biotechnology a small, medium or large cap company?

No. Sana Biotechnology is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 835 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Sana Biotechnology makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves SANA stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Sana Biotechnology: A Shot At Diabetes (Seeking Alpha)
  • SANA Jan 2027 2.000 call (SANA270115C00002000) stock price, news, quote and history (Yahoo Finance UK)
  • AAL Stock Advances After Hours Following Report Of UAL CEO Combining His Past And Present Companies (Stocktwits)
  • A workplace AI from Workday is designed to resolve employee requests before they become tickets. (Stock Titan)
  • Is Sana Biotechnology (SANA) Turning Cost Discipline Into a More Durable Investment Narrative? (Simply Wall Street)

Follow SANA in your daily brief

Each trading day at 5 PM ET we post what happened to Sana Biotechnology and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow SANA

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Sana Biotechnology stock

What does Sana Biotechnology do?

Sana Biotechnology trades on the Nasdaq under the ticker SANA. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 835 million dollars.

What is the ticker symbol for Sana Biotechnology?

Sana Biotechnology trades under the ticker SANA on the Nasdaq.

What is Sana Biotechnology's market cap?

Sana Biotechnology is a small cap stock with a market cap of about 835 million dollars.

How does Sana Biotechnology make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves SANA stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow SANA stock every day?

Add SANA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow SANA daily

A free brief on Sana Biotechnology and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare SANA: SANA vs ARGX, SANA vs RVMD, SANA vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed